Manohar, S., and N. Leung. 2018. Cisplatin nephrotoxicity: A review of the literature. Journal of nephrology 31 (1): 15–25.

CAS  PubMed  Article  Google Scholar 

Fennell, D., et al. 2016. Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer. Cancer treatment reviews 44: 42–50.

CAS  PubMed  Article  Google Scholar 

Boot, A., et al. 2018. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. Genome research 28 (5): 654–665.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hassani, M., et al. 2019. Cytotoxic effects of duloxetine on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arquivos de Gastroenterologia 56: 372–376.

PubMed  Article  Google Scholar 

Aldossary, S.A. 2019. Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomedical and Pharmacology Journal 12 (1): 7–15.

CAS  Article  Google Scholar 

Guo, J., et al. 2018. Ferroptosis: A novel anti-tumor action for cisplatin. Cancer research and treatment: Official journal of Korean Cancer Association 50 (2): 445.

CAS  Article  Google Scholar 

Shi, M., et al. 2018. Cisplatin nephrotoxicity as a model of chronic kidney disease. Laboratory Investigation 98 (8): 1105–1121.

CAS  PubMed  Article  Google Scholar 

Shokrzadeh, M., et al. 2019. Metallothionein-2A (rs1610216&rs28366003) gene polymorphisms and the risk of stomach adenocarcinoma. Arquivos de Gastroenterologia 56: 367–371.

PubMed  Article  Google Scholar 

Sooklert, K., et al. 2016. Cytoprotective effect of glutaraldehyde erythropoietin on HEK293 kidney cells after silver nanoparticle exposure. International Journal of Nanomedicine 11: 597.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ghassemi-Barghi, N., et al. 2016. Role of recombinant human erythropoietin loading chitosan-tripolyphosphate nanoparticles in busulfan-induced genotoxicity: Analysis of DNA fragmentation via comet assay in cultured HepG2 cells. Toxicology in Vitro 36: 46–52.

CAS  PubMed  Article  Google Scholar 

Shokrzadeh, M., and N. Ghassemi-Barghi. 2018. Melatonin loading chitosan-tripolyphosphate nanoparticles: Application in attenuating etoposide-induced genotoxicity in HepG2 cells. Pharmacology 102 (1–2): 74–80.

CAS  PubMed  Article  Google Scholar 

Martin, C., et al. 2017. Erythropoietin-induced cytoprotection in intestinal epithelial cells is linked to system Xc. Experimental Cell Research 352 (2): 202–206.

CAS  PubMed  Article  Google Scholar 

Schmidt, L.S., et al. 2018. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: A study protocol for a randomized controlled trial. Trials 19 (1): 1–10.

Article  Google Scholar 

Shokrzadeh, M., et al. 2021. Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. Naunyn-Schmiedeberg’s Archives of Pharmacology 394 (8): 1803–1813.

CAS  PubMed  Article  Google Scholar 

Macdougall, I.C. 2018. Development of recombinant erythropoietin and erythropoietin analogs. In Textbook of nephro-endocrinology, 217–232. Elsevier.

Chapter  Google Scholar 

Shokrzadeh, M., M. Etebari, and N. Ghassemi-Barghi. 2020. An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicology in Vitro 66: 104864.

CAS  PubMed  Article  Google Scholar 

Hache, G., et al. 2016. ARA290, a specific agonist of erythropoietin/CD131 heteroreceptor, improves circulating endothelial progenitors’ angiogenic potential and homing ability. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, 46(4): 390–397.

Watanabe, M., et al. 2016. An engineered innate repair receptor agonist, ARA 290, protects rat islets from cytokine-induced apoptosis. Journal of Diabetes and Metabolism 7 (708): 2.

Google Scholar 

Shokrzadeh, M., M. Etebari, and N. Ghassemi-Barghi. 2020. An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicology in Vitro, p. 104864.

Ghassemi-Barghi, N., M. Etebari, and A. Jafarian-Dehkordi. 2017. Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells. Toxicology Mechanisms and Methods 27 (1): 52–57.

CAS  PubMed  Article  Google Scholar 

Zhang, H., et al. 2018. EPO derivative ARA290 attenuates early renal allograft injury in rats by targeting NF.

Zhang, Y., et al. 2017. Renoprotection and mechanisms of erythropoietin and its derivatives helix b surface peptide in kidney injuries. Current Protein and Peptide Science 18 (12): 1183–1190.

CAS  PubMed  Google Scholar 

Dobyan, D.C., et al. 1980. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. Journal of Pharmacology and Experimental Therapeutics, 213(3): 551–556.

Kumar, P., A. Nagarajan, and P.D. Uchil. 2018. Analysis of cell viability by the MTT assay. Cold Spring Harbor Protocols, 2018(6): p. pdb. prot095505.

Hassani, M., et al. 2019. Cytotoxic effects of duloxetine on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arquivos de gastroenterologia, 56 (4): 372–376.

Shokrzadeh, M., and N. Ghassemi-Barghi. 2018. Application of comet assay to assess the protective effect of amifostine on doxorubicin-induced DNA damage in human hepatoma cells. EC Pharmacology and Toxicology 6: 500–508.

Google Scholar 

Shokrzadeh, M., et al. 2019. Cytotoxic effects of aripiprazole on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arquivos de gastroenterologia, 56(2): 155–159.

Yao, J., et al. 2019. Reversing ROS-mediated neurotoxicity by chlorogenic acid involves its direct antioxidant activity and activation of Nrf2-ARE signaling pathway. BioFactors 45 (4): 616–626.

CAS  PubMed  Google Scholar 

Moura, C.S., et al. 2017. Modulatory effects of arginine, glutamine and branched-chain amino acids on heat shock proteins, immunity and antioxidant response in exercised rats. Food & function 8 (9): 3228–3238.

CAS  Article  Google Scholar 

Ren, Y., et al. 2019. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice. Pharmacological Research 146: 104318.

PubMed  Article  Google Scholar 

Wang, L., et al. 2019. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. IUBMB Life 71 (1): 45–56.

CAS  PubMed  Article  Google Scholar 

Clausen, B.H., et al. 2008. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. Journal of neuroinflammation 5 (1): 46.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Shokrzadeh, M., et al. 2018. Serum cytokine of IL-2, IL-10 and IL-12 levels in patients with stomach adenocarcinoma. Arquivos de gastroenterologia 55: 385–389.

PubMed  Article  Google Scholar 

Baharara, J., et al. 2016. Induction of apoptosis by green synthesized gold nanoparticles through activation of caspase-3 and 9 in human cervical cancer cells. Avicenna journal of medical biotechnology 8 (2): 75.

PubMed  PubMed Central  Google Scholar 

Zhong, Y., et al. 2017. Apigenin attenuates patulin-induced apoptosis in HEK293 cells by modulating ROS-mediated mitochondrial dysfunction and caspase signal pathway. Toxicon 137: 106–113.

CAS  PubMed  Article  Google Scholar 

Lee, Y., et al. 2012. Transient exposure to hydrogen peroxide inhibits the ubiquitination of phosphorylated IκBα in TNFα-stimulated HEK293 cells. Experimental & molecular medicine 44 (8): 513–520.

CAS  Article  Google Scholar 

Monjezi, A., et al. 2022. Resistin, TNF-α, and microRNA 124–3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy. International Journal of Diabetes in Developing Countries 42 (1): 62–69.

CAS  Article  Google Scholar 

Yu, T., et al. 2018. Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro. International Immunopharmacology 55: 290–296.

CAS  PubMed  Article  Google Scholar 

Wang, Y., et al. 2018. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury. Cell death & disease 9 (11): 1–14.

Google Scholar 

Yu, W., et al. 2018. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Scientific reports 8 (1): 1–12.

Google Scholar 

Wang, S.-W., et al. 2018. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation. Food and chemical toxicology 114: 227–236.

CAS  PubMed  Article  Google Scholar 

Wang, Z., et al. 2020. Kaempferol ameliorates cisplatin induced nephrotoxicity by modulating oxidative stress, inflammation and apoptosis via ERK and NF-κB pathways. AMB Express 10 (1): 1–11.

CAS  Article  Google Scholar 

Li, S., et al. 2019. NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation. Experimental Cell Research 383 (1): 111488.

CAS  PubMed  Article  Google Scholar 

Alibakhshi, T., et al. 2018. Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Biomedicine & Pharmacotherapy 105: 225–232.

CAS  Article  Google Scholar 

Saifi, M.A., et al. 2019. Protective effect of nanoceria on cisplatin-induced nephrotoxicity by amelioration of oxidative stress and pro-inflammatory mechanisms. Biological Trace Element Research 189 (1): 145–156.

CAS  PubMed  Article  Google Scholar 

Abdel-Wahab, W.M., and F.I. Moussa. 2019. Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation. Drug design, development and therapy 13: 1155.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Heij, L., et al. 2012. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: A randomized, double-blind pilot study. Molecular medicine 18 (11): 1430–1436.

CAS  PubMed  PubMed Central  Article